Avalon GloboCare (NASDAQ:ALBT) Shares Set to Reverse Split on Monday, October 28th

Avalon GloboCare Corp. (NASDAQ:ALBT)’s stock is going to reverse split on the morning of Monday, October 28th. The 1-15 reverse split was announced on Thursday, October 24th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, October 25th.

Avalon GloboCare Stock Up 0.2 %

NASDAQ ALBT traded up $0.00 during trading hours on Thursday, reaching $0.20. 2,570,287 shares of the company were exchanged, compared to its average volume of 2,414,625. The stock has a market capitalization of $2.25 million, a P/E ratio of -0.14 and a beta of 0.31. Avalon GloboCare has a 1 year low of $0.16 and a 1 year high of $1.44. The business’s 50 day simple moving average is $0.25 and its 200-day simple moving average is $0.34.

Avalon GloboCare (NASDAQ:ALBT) last issued its quarterly earnings results on Monday, August 19th. The company reported ($0.19) earnings per share (EPS) for the quarter. The firm had revenue of $0.33 million for the quarter.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.